Vanguard Group Inc. Grows Stock Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Vanguard Group Inc. raised its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 382,856 shares of the medical instruments supplier's stock after buying an additional 5,274 shares during the quarter. Vanguard Group Inc. owned 7.05% of Mesa Laboratories worth $50,487,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. FMR LLC lifted its position in shares of Mesa Laboratories by 34.1% during the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier's stock valued at $51,000 after acquiring an additional 100 shares during the period. Amundi raised its holdings in shares of Mesa Laboratories by 81.6% during the fourth quarter. Amundi now owns 661 shares of the medical instruments supplier's stock valued at $91,000 after purchasing an additional 297 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of Mesa Laboratories during the fourth quarter valued at about $132,000. Captrust Financial Advisors bought a new position in shares of Mesa Laboratories during the 3rd quarter worth about $207,000. Finally, Berry Wealth Group LP grew its stake in shares of Mesa Laboratories by 5.3% in the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock valued at $219,000 after buying an additional 83 shares during the period. 90.60% of the stock is currently owned by institutional investors.

Mesa Laboratories Stock Up 1.3 %

MLAB stock traded up $1.43 during trading on Tuesday, reaching $115.52. 45,405 shares of the stock were exchanged, compared to its average volume of 38,838. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a twelve month low of $83.68 and a twelve month high of $155.12. The firm's 50 day moving average is $129.73 and its 200 day moving average is $128.11. The firm has a market cap of $627.74 million, a P/E ratio of -2.50 and a beta of 0.92.

Remove Ads

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. As a group, research analysts forecast that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories's dividend payout ratio is currently -1.38%.

Insider Transactions at Mesa Laboratories

In related news, CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the sale, the chief executive officer now owns 43,337 shares in the company, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 4.40% of the company's stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.